257 related articles for article (PubMed ID: 36216838)
1. Spatio-temporal metabolic rewiring in the brain of TgF344-AD rat model of Alzheimer's disease.
Muñoz-Moreno E; Simões RV; Tudela R; López-Gil X; Soria G
Sci Rep; 2022 Oct; 12(1):16958. PubMed ID: 36216838
[TBL] [Abstract][Full Text] [Related]
2. Prodromal neuroinflammatory, cholinergic and metabolite dysfunction detected by PET and MRS in the TgF344-AD transgenic rat model of AD: a collaborative multi-modal study.
Chaney AM; Lopez-Picon FR; Serrière S; Wang R; Bochicchio D; Webb SD; Vandesquille M; Harte MK; Georgiadou C; Lawrence C; Busson J; Vercouillie J; Tauber C; Buron F; Routier S; Reekie T; Snellman A; Kassiou M; Rokka J; Davies KE; Rinne JO; Salih DA; Edwards FA; Orton LD; Williams SR; Chalon S; Boutin H
Theranostics; 2021; 11(14):6644-6667. PubMed ID: 34093845
[TBL] [Abstract][Full Text] [Related]
3. Altered neurochemical profile in the McGill-R-Thy1-APP rat model of Alzheimer's disease: a longitudinal in vivo 1 H MRS study.
Nilsen LH; Melø TM; Saether O; Witter MP; Sonnewald U
J Neurochem; 2012 Nov; 123(4):532-41. PubMed ID: 22943908
[TBL] [Abstract][Full Text] [Related]
4. Neurochemical and cognitive changes precede structural abnormalities in the TgF344-AD rat model.
Fowler CF; Goerzen D; Devenyi GA; Madularu D; Chakravarty MM; Near J
Brain Commun; 2022; 4(2):fcac072. PubMed ID: 35434622
[TBL] [Abstract][Full Text] [Related]
5. In vivo 1H-magnetic resonance spectroscopy can detect metabolic changes in APP/PS1 mice after donepezil treatment.
Westman E; Spenger C; Oberg J; Reyer H; Pahnke J; Wahlund LO
BMC Neurosci; 2009 Apr; 10():33. PubMed ID: 19351388
[TBL] [Abstract][Full Text] [Related]
6. Regional Myo-Inositol, Creatine, and Choline Levels Are Higher at Older Age and Scale Negatively with Visuospatial Working Memory: A Cross-Sectional Proton MR Spectroscopy Study at 7 Tesla on Normal Cognitive Ageing.
Lind A; Boraxbekk CJ; Petersen ET; Paulson OB; Siebner HR; Marsman A
J Neurosci; 2020 Oct; 40(42):8149-8159. PubMed ID: 32994337
[TBL] [Abstract][Full Text] [Related]
7. Early ultrasonic vocalization deficits and related thyroarytenoid muscle pathology in the transgenic TgF344-AD rat model of Alzheimer's disease.
Rudisch DM; Krasko MN; Barnett DGS; Mueller KD; Russell JA; Connor NP; Ciucci MR
Front Behav Neurosci; 2023; 17():1294648. PubMed ID: 38322496
[TBL] [Abstract][Full Text] [Related]
8. Whole-brain patterns of (1)H-magnetic resonance spectroscopy imaging in Alzheimer's disease and dementia with Lewy bodies.
Su L; Blamire AM; Watson R; He J; Hayes L; O'Brien JT
Transl Psychiatry; 2016 Aug; 6(8):e877. PubMed ID: 27576166
[TBL] [Abstract][Full Text] [Related]
9. Age-related changes in brain metabolites and cognitive function in APP/PS1 transgenic mice.
Chen SQ; Cai Q; Shen YY; Wang PJ; Teng GJ; Zhang W; Zang FC
Behav Brain Res; 2012 Nov; 235(1):1-6. PubMed ID: 22828014
[TBL] [Abstract][Full Text] [Related]
10. Neurophysiological signals as predictive translational biomarkers for Alzheimer's disease treatment: effects of donepezil on neuronal network oscillations in TgF344-AD rats.
Stoiljkovic M; Kelley C; Horvath TL; Hajós M
Alzheimers Res Ther; 2018 Oct; 10(1):105. PubMed ID: 30301466
[TBL] [Abstract][Full Text] [Related]
11. 1H NMR metabolomic signatures in five brain regions of the AβPPswe Tg2576 mouse model of Alzheimer's disease at four ages.
Lalande J; Halley H; Balayssac S; Gilard V; Déjean S; Martino R; Francés B; Lassalle JM; Malet-Martino M
J Alzheimers Dis; 2014; 39(1):121-43. PubMed ID: 24145382
[TBL] [Abstract][Full Text] [Related]
12. Deficits in synaptic function occur at medial perforant path-dentate granule cell synapses prior to Schaffer collateral-CA1 pyramidal cell synapses in the novel TgF344-Alzheimer's Disease Rat Model.
Smith LA; McMahon LL
Neurobiol Dis; 2018 Feb; 110():166-179. PubMed ID: 29199135
[TBL] [Abstract][Full Text] [Related]
13. Late post-natal neurometabolic development in healthy male rats using
Račkayová V; Simicic D; Donati G; Braissant O; Gruetter R; McLin VA; Cudalbu C
J Neurochem; 2021 May; 157(3):508-519. PubMed ID: 33421129
[TBL] [Abstract][Full Text] [Related]
14. Short echo time proton magnetic resonance spectroscopy in Alzheimer's disease: a longitudinal multiple time point study.
Schott JM; Frost C; MacManus DG; Ibrahim F; Waldman AD; Fox NC
Brain; 2010 Nov; 133(11):3315-22. PubMed ID: 20739347
[TBL] [Abstract][Full Text] [Related]
15. MRI and MRS alterations in the preclinical phase of murine prion disease: association with neuropathological and behavioural changes.
Broom KA; Anthony DC; Lowe JP; Griffin JL; Scott H; Blamire AM; Styles P; Perry VH; Sibson NR
Neurobiol Dis; 2007 Jun; 26(3):707-17. PubMed ID: 17490889
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal investigation of neuroinflammation and metabolite profiles in the APP
Chaney A; Bauer M; Bochicchio D; Smigova A; Kassiou M; Davies KE; Williams SR; Boutin H
J Neurochem; 2018 Feb; 144(3):318-335. PubMed ID: 29124761
[TBL] [Abstract][Full Text] [Related]
17. Spatiotemporal immunolocalisation of REST in the brain of healthy ageing and Alzheimer's disease rats.
Mampay M; Velasco-Estevez M; Rolle SO; Chaney AM; Boutin H; Dev KK; Moeendarbary E; Sheridan GK
FEBS Open Bio; 2021 Jan; 11(1):146-163. PubMed ID: 33185010
[TBL] [Abstract][Full Text] [Related]
18. Brain metabolite concentration and dementia severity in Alzheimer's disease: a (1)H MRS study.
Huang W; Alexander GE; Chang L; Shetty HU; Krasuski JS; Rapoport SI; Schapiro MB
Neurology; 2001 Aug; 57(4):626-32. PubMed ID: 11524470
[TBL] [Abstract][Full Text] [Related]
19. Changes in metabolite ratios after treatment with rivastigmine in Alzheimer's disease: a nonrandomised controlled trial with magnetic resonance spectroscopy.
Modrego PJ; Pina MA; Fayed N; Díaz M
CNS Drugs; 2006; 20(10):867-77. PubMed ID: 16999455
[TBL] [Abstract][Full Text] [Related]
20. Altered basal forebrain function during whole-brain network activity at pre- and early-plaque stages of Alzheimer's disease in TgF344-AD rats.
van den Berg M; Adhikari MH; Verschuuren M; Pintelon I; Vasilkovska T; Van Audekerke J; Missault S; Heymans L; Ponsaerts P; De Vos WH; Van der Linden A; Keliris GA; Verhoye M
Alzheimers Res Ther; 2022 Oct; 14(1):148. PubMed ID: 36217211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
